When extrapolating to doses for patients with moderate to severe RI, in addition to accounting for physiological changes relating to the cancer itself (captured by the Sim-Cancer population), changes in CYP3A4 and potentially other CYP enzymes may need to be considered. The gene discussed is CYP3A4; the disease is cancer.